...
首页> 外文期刊>Brain: A journal of neurology >Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine.
【24h】

Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine.

机译:DYT1肌张力障碍小鼠模型纹状体中双向突触可塑性的损害:内源性乙酰胆碱的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

DYT1 dystonia is a severe form of inherited dystonia, characterized by involuntary twisting movements and abnormal postures. It is linked to a deletion in the dyt1 gene, resulting in a mutated form of the protein torsinA. The penetrance for dystonia is incomplete, but both clinically affected and non-manifesting carriers of the DYT1 mutation exhibit impaired motor learning and evidence of altered motor plasticity. Here, we characterized striatal glutamatergic synaptic plasticity in transgenic mice expressing either the normal human torsinA or its mutant form, in comparison to non-transgenic (NT) control mice. Medium spiny neurons recorded from both NT and normal human torsinA mice exhibited normal long-term depression (LTD), whereas in mutant human torsinA littermates LTD could not be elicited. In addition, although long-term potentiation (LTP) could be induced in all the mice, it was greater in magnitude in mutant human torsinA mice. Low-frequency stimulation (LFS) can revert potentiated synapses to resting levels, a phenomenon termed synaptic depotentiation. LFS induced synaptic depotentiation (SD) both in NT and normal human torsinA mice, but not in mutant human torsinA mice. Since anti-cholinergic drugs are an effective medical therapeutic option for the treatment of human dystonia, we reasoned that an excess in endogenous acetylcholine could underlie the synaptic plasticity impairment. Indeed, both LTD and SD were rescued in mutant human torsinA mice either by lowering endogenous acetylcholine levels or by antagonizing muscarinic M1 receptors. The presence of an enhanced acetylcholine tone was confirmed by the observation that acetylcholinesterase activity was significantly increased in the striatum of mutant human torsinA mice, as compared with both normal human torsinA and NT littermates. Moreover, we found similar alterations of synaptic plasticity in muscarinic M2/M4 receptor knockout mice, in which an increased striatal acetylcholine level has been documented. The loss of LTD and SD on one hand, and the increase in LTP on the other, demonstrate that a 'loss of inhibition' characterizes the impairment of synaptic plasticity in this model of DYT1 dystonia. More importantly, our results indicate that an unbalanced cholinergic transmission plays a pivotal role in these alterations, providing a clue to understand the ability of anticholinergic agents to restore motor deficits in dystonia.
机译:DYT1肌张力障碍是遗传性肌张力障碍的一种严重形式,其特征是不自主的扭转运动和异常姿势。它与dyt1基因的缺失相关,导致了torsinA蛋白的突变形式。肌张力障碍的外在性尚不完全,但受DYT1突变影响的临床和非表现携带者均显示出运动学习受损和运动可塑性改变的证据。在这里,我们与非转基因(NT)对照小鼠相比,在表达正常人TorsA或其突变体形式的转基因小鼠中表征了纹状体谷氨酸能突触可塑性。从NT和正常人torsinA小鼠中记录的中棘神经元表现出正常的长期抑郁(LTD),而在突变型人torsinA中未发现同窝幼虫LTD。另外,尽管可以在所有小鼠中诱导长期增强(LTP),但是在突变的人torsA小鼠中其强度更大。低频刺激(LFS)可以将增强的突触恢复到静止状态,这种现象称为突触去势。 LFS在NT和正常人torsinA小鼠中均诱导突触去势(SD),但在突变人torsinA小鼠中均不诱导。由于抗胆碱能药物是治疗人肌张力障碍的有效医疗选择,因此我们认为内源性乙酰胆碱过量可能是突触可塑性受损的基础。实际上,通过降低内源性乙酰胆碱水平或拮抗毒蕈碱型M1受体,在突变型人torsinA小鼠中挽救了LTD和SD。与正常人的torsinA和NT同窝仔相比,突变型人torsinA小鼠的纹状体中的乙酰胆碱酯酶活性显着增加,从而证实了乙酰胆碱调增强。此外,我们发现毒蕈碱M2 / M4受体敲除小鼠中突触可塑性的类似变化,其中已记录了增加的纹状体乙酰胆碱水平。一方面,LTD和SD的丧失,另一方面,LTP的升高,表明在这种DYT1肌张力障碍模型中,“抑制作用的丧失”是突触可塑性受损的特征。更重要的是,我们的结果表明,胆碱能的不平衡传递在这些改变中起着关键作用,为了解抗胆碱能药恢复肌张力障碍运动障碍的能力提供了线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号